Document Detail

Imaging practices in the diagnosis and management of gestational trophoblastic disease: an assessment.
MedLine Citation:
PMID:  22696814     Owner:  NLM     Status:  In-Process    
This article discusses several of the problems associated with imaging in gestational trophoblastic disease based on critical assessment of the literature. (1) Ultrasound scanning has revolutionized the diagnosis of abnormalities of the first trimester of pregnancy. Fetal death can now be diagnosed as early as 6 weeks of gestation, resulting in uterine evacuation. Histologic and genetic analysis of the conceptus therefore becomes essential as otherwise the diagnosis of hydatidiform mole and other chromosomal anomalies of the fetus may be missed. If such investigation is not performed, human chorionic gonadotropin should be measured after early pregnancy loss to make sure it is negative. (2) The routine use of ultrasound or Doppler flow to follow hydatidiform mole regression is clinically and fiscally counterproductive. (3) To diagnose lung metastases and assess the FIGO risk factor score, chest X-ray is mandated. However, CT scanning may show lung micrometastases indicative of possible chemotherapy resistance. (4) positron emission tomography scanning in trophoblastic neoplasia needs to be validated. Previous studies have been small, with some 30% false positive and false negative findings. The International Society for the Study of Trophoblastic Disease should undertake carefully designed prospective studies to validate imaging practices in the management of trophoblastic disease.
Ernest I Kohorn
Related Documents :
21254924 - Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid anti...
21564404 - Spontaneous spinal epidural hematoma at the 16th week of a twin pregnancy.
1433234 - The oeis complex (omphalocele-exstrophy-imperforate anus-spinal defects): recurrence in...
7387924 - Small biparietal diameter of fetuses with spina bifida: implications for antenatal scre...
15694104 - Ultrasound biometry of arabian fetuses.
2917494 - Studies with choriocarcinoma and normal pregnancy serum chorionic gonadotrophin.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  57     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:    2012 May-Jun
Date Detail:
Created Date:  2012-06-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  207-10     Citation Subset:  IM    
Trophoblast Disease Center, Department of Gynecology, Yale University School of Medicine, 333 Cedar Street, FMB 322, New Haven, CT 06510, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The incidence of gestational trophoblastic disease in Italy: a multicenter survey.
Next Document:  A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia.